Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07143318
PHASE1

First-in-Human Single and Multiple Dose of KLA578-1 for Injection

Sponsor: Sichuan Kelun Pharmaceutical Co., Ltd

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the safety and tolerability and pharmacokinetics of single and multiple doses of KLA578-1 for injection in healthy volunteers

Official title: A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of KLA578-1 for Injection in Healthy Volunteers

Key Details

Gender

All

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

48

Start Date

2025-06-05

Completion Date

2026-05-31

Last Updated

2025-08-27

Healthy Volunteers

Yes

Interventions

DRUG

KLA578-1 for injection

Intravenous injection, single dose

DRUG

Etopcoxib Tablets

P.O., single dose

Locations (1)

The Third Xiangya Hospital of Central South University

Changsha, Hunan, China